Recent advances in the treatment of common intestinal helminths.
D000871:Anthelmintics / Q000627:therapeutic use*; D001196:Ascariasis / Q000188:drug therapy; D002590:Cestode Infections / Q000188:drug therapy; D004006:Dichlorvos / Q000008:administration & dosage / Q000627:therapeutic use; D005211:Fascioliasis / Q000188:drug therapy; D006373:Helminthiasis / Q000188:drug therapy*; D006725:Hookworm Infections / Q000188:drug therapy; D006801:Humans; D006925:Hymenolepiasis / Q000188:drug therapy; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy*; D009534:Niclosamide / Q000008:administration & dosage / Q000627:therapeutic use; D010123:Oxyuriasis / Q000188:drug therapy; D010303:Paromomycin / Q000008:administration & dosage / Q000627:therapeutic use; D011715:Pyrantel / Q000008:administration & dosage / Q000627:therapeutic use; D013322:Strongyloidiasis / Q000188:drug therapy; D013773:Tetramisole / Q000008:administration & dosage / Q000627:therapeutic use; D014257:Trichuriasis / Q000188:drug therapy
D000871:Anthelmintics; D007093:Imidazoles; D011715:Pyrantel; D010303:Paromomycin; D004006:Dichlorvos; D009534:Niclosamide; D013773:Tetramisole